Furthermore, emodin can also impact diabetic retinopathy and cataract through inhibition of retinal neovascularization via modulation of HIF-1α/VEGF signaling pathway and through decreasing expressions of VEGFA, HIF-1α, and PHD-2 [81]. This evidence concerns the gene HIF1A and diabetic retinopathy.